Pharvaris N.V. financial data

Symbol
PHVS on Nasdaq
Location
Leiden
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 07 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.4M shares +4%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 23.1M EUR +57.1%
General And Administrative Expense 11.3M EUR +45.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 291M EUR -26.9%
Liabilities 23.6M EUR +61.2%